Clostridium difficile infection: new developments in epidemiology and pathogenesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Clostridium difficile is now considered to be one of the most important causes of health care-associated infections. C. difficile infections are also emerging in the community and in animals used for food, and are no longer viewed simply as unpleasant complications that follow antibiotic therapy. Since 2001, the prevalence and severity of C. difficile infection has increased significantly, which has led to increased research interest and the discovery of new virulence factors, and has expanded and focused the development of new treatment and prevention regimens. This Review summarizes the recent epidemiological changes in C. difficile infection, our current knowledge of C. difficile virulence factors and the clinical outcomes of C. difficile infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [45]
Citations
Cites
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“It is becoming evident from 16S ribosomal RNA sequencing that disruption of the gut microbiota following antibiotic treatment is much greater than was previously realize”
BackgroundAn Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome
Sebaihia, M., Wren, B. W., Mullany, P., Fairweather, N. F., Minton, N., Stabler, R., Thomson, N. R., Roberts, A. P., Cerdeño-Tárraga, A. M., Wang, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1830 · Cited by 879
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872
Emergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
Toxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
The ClosTron: a universal gene knock-out system for the genus Clostridium
Heap, J. T., Pennington, O. J., Cartman, S. T., Carter, G. P., & Minton, N. P. (2007) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.05.021 · Cited by 663
Goorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W., & Kuijper, E. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592257 · Cited by 637
Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
The Comprehensive Sourcebook of Bacterial Protein Toxins
(2015) · Elsevier eBooks · doi:10.1016/c2013-0-14258-4 · Cited by 605
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Riggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R. L. P., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521854 · Cited by 550
Clinical Recognition and Diagnosis of Clostridium difficile Infection
Bartlett, J. G., & Gerding, D. N. (2008) · Clinical Infectious Diseases · doi:10.1086/521863 · Cited by 527
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
Stubbs, S. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00162-2 · Cited by 439
Effects of Clostridium difficile toxins given intragastrically to animals
Lyerly, D. M., Saum, K. E., MacDonald, D. K., & Wilkins, T. D. (1985) · Infection and Immunity · doi:10.1128/iai.47.2.349-352.1985 · Cited by 400
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea
Shim, J. K., Johnson, S., Samore, M. H., Bliss, D. Z., & Gerding, D. N. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08062-8 · Cited by 391
Johnson, S., Samore, M. H., Farrow, K. A., Killgore, G. E., Tenover, F. C., Lyras, D., Rood, J. I., DeGirolami, P., Baltch, A. L., Rafferty, M. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412203 · Cited by 379
A case-control study of community-associated Clostridium difficile infection
Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn163 · Cited by 372
Lamontagne, F., Labb??, A.-C., Haeck, O., Lesur, O., Lalancette, M., Patino, C., Leblanc, M., Laverdi??re, M., & P??pin, J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000236628.79550.e5 · Cited by 359
Samore, M. H., Venkataraman, L., DeGirolami, P. C., Arbeit, R. D., & Karchmer, A. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90008-x · Cited by 350
Riegler, M., Sedivy, R., Pothoulakis, C., Hamilton, G., Zacherl, J., Bischof, G., Cosentini, E., Feil, W., Schiessel, R., & LaMont, J. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117885 · Cited by 340
Killgore, G., Thompson, A., Johnson, S., Brazier, J., Kuijper, E., Pepin, J., Frost, E. H., Savelkoul, P., Nicholson, B., van den Berg, R. J., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-07 · Cited by 337
Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review
Planche, T., Aghaizu, A., Holliman, R., Riley, P., Poloniecki, J., Breathnach, A., & Krishna, S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70233-0 · Cited by 334
Definition of the single integration site of the pathogenicity locus in Clostridium difficile
Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M., & von Eichel-Streiber, C. (1996) · Gene · doi:10.1016/s0378-1119(96)00398-8 · Cited by 330
Valiquette, L., Cossette, B., Garant, M.-P., Diab, H., & Pépin, J. (2007) · Clinical Infectious Diseases · doi:10.1086/519258 · Cited by 330
Rupnik, M., Avesani, V., Janc, M., von Eichel-Streiber, C., & Delmée, M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.8.2240-2247.1998 · Cited by 323
Kim, J., Smathers, S. A., Prasad, P., Leckerman, K. H., Coffin, S., & Zaoutis, T. (2008) · Pediatrics · doi:10.1542/peds.2008-0469 · Cited by 321
Johnson, S., Gerding, D. N., Olson, M. M., Weiler, M. D., Hughes, R. A., Clabots, C. R., & Peterson, L. R. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90462-m · Cited by 317
Bartlett, J. G. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_4.s265 · Cited by 309
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Kuijper, E. J., Barbut, F., Brazier, J. S., Kleinkauf, N., Eckmanns, T., Lambert, M. L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D. J., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.31.18942-en · Cited by 287
Perelle, S., Gibert, M., Bourlioux, P., Corthier, G., & Popoff, M. R. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1402-1407.1997 · Cited by 283
Environmental Control to Reduce Transmission of Clostridium difficile
Mayfield, J. L., Leet, T., Miller, J., & Mundy, L. M. (2000) · Clinical Infectious Diseases · doi:10.1086/318149 · Cited by 279
Wilcox, M. H., Fawley, W. N., Wigglesworth, N., Parnell, P., Verity, P., & Freeman, J. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(02)00400-0 · Cited by 271
&NA; (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000202057.19407.4d · Cited by 271
Keel, K., Brazier, J. S., Post, K. W., Weese, S., & Songer, J. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00224-07 · Cited by 266
Clostridium difficile in Retail Meat Products, USA, 2007
Songer, J. G., Trinh, H. T., Killgore, G. E., Thompson, A. D., McDonald, L. C., & Limbago, B. M. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1505.081071 · Cited by 265
The distribution of Clostridium difficile in the environment of South Wales
Al Saif, N., & BRAZIER, J. S. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-45-2-133 · Cited by 259
Large clostridial cytotoxins — a family of glycosyltransferases modifying small GTP-binding proteins
VONEICHELSTREIBER, C., BOQUET, P., SAUERBORN, M., & THELESTAM, M. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10061-5 · Cited by 256
Clostridium difficile in Retail Ground Meat, Canada
Rodriguez-Palacios, A., Staempfli, H. R., Duffield, T., & Weese, J. S. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1303.060988 · Cited by 254
Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor
Mani, N., & Dupuy, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101126598 · Cited by 252
Gaynes, R., Rimland, D., Killum, E., Ken Lowery, H., Johnson II, T. M., Killgore, G., & Tenover, F. C. (2004) · Clinical Infectious Diseases · doi:10.1086/381551 · Cited by 251
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Baines, S. D., O'Connor, R., Freeman, J., Fawley, W. N., Harmanus, C., Mastrantonio, P., Kuijper, E. J., & Wilcox, M. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn313 · Cited by 247
Autocatalytic cleavage of Clostridium difficile toxin B
Reineke, J., Tenzer, S., Rupnik, M., Koschinski, A., Hasselmayer, O., Schrattenholz, A., Schild, H., & von Eichel-Streiber, C. (2007) · Nature · doi:10.1038/nature05622 · Cited by 244
Hu, M. Y., Katchar, K., Kyne, L., Maroo, S., Tummala, S., Dreisbach, V., Xu, H., Leffler, D. A., & Kelly, C. P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.038 · Cited by 242
Muto, C. A., Blank, M. K., Marsh, J. W., Vergis, E. N., O'Leary, M. M., Shutt, K. A., Pasculle, A. W., Pokrywka, M., Garcia, J. G., Posey, K., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/522654 · Cited by 241
Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Clostridium difficile toxin expression is inhibited by the novel regulator TcdC
Matamouros, S., England, P., & Dupuy, B. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05739.x · Cited by 236
Repression of Clostridium difficile toxin gene expression by CodY
Dineen, S. S., Villapakkam, A. C., Nordman, J. T., & Sonenshein, A. L. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05906.x · Cited by 230
Sloan, L. M., Duresko, B. J., Gustafson, D. R., & Rosenblatt, J. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00032-08 · Cited by 215
Clostridium difficile PCR Ribotypes in Calves, Canada
Rodriguez-Palacios, A., Stämpfli, H. R., Duffield, T., Peregrine, A. S., Trotz-Williams, L. A., Arroyo, L. G., Brazier, J. S., & Weese, J. S. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.051581 · Cited by 213
Toxinotype V Clostridium difficile in Humans and Food Animals
Jhung, M. A., Thompson, A. D., Killgore, G. E., Zukowski, W. E., Songer, G., Warny, M., Johnson, S., Gerding, D. N., McDonald, L. C., & Limbago, B. M. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1407.071641 · Cited by 212
Clostridium difficile: An important pathogen of food animals
Songer, J. G., & Anderson, M. A. (2006) · Anaerobe · doi:10.1016/j.anaerobe.2005.09.001 · Cited by 208
Ticehurst, J. R., Aird, D. Z., Dam, L. M., Borek, A. P., Hargrove, J. T., & Carroll, K. C. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.1145-1149.2006 · Cited by 208
Curry, S. R., Marsh, J. W., Muto, C. A., O'Leary, M. M., Pasculle, A. W., & Harrison, L. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01599-06 · Cited by 204
Dendukuri, N. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050350 · Cited by 203
Hubert, B., Loo, V. G., Bourgault, A.-M., Poirier, L., Dascal, A., Fortin, E., Dionne, M., & Lorange, M. (2007) · Clinical Infectious Diseases · doi:10.1086/510391 · Cited by 196
Geric, B., Carman, R. J., Rupnik, M., Genheimer, C. W., Sambol, S. P., Lyerly, D. M., Gerding, D. N., & Johnson, S. (2006) · The Journal of Infectious Diseases · doi:10.1086/501368 · Cited by 196
Egerer, M., Giesemann, T., Jank, T., Satchell, K. J. F., & Aktories, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703062200 · Cited by 194
Transcription Analysis of the Genes tcdA‐E of the Pathogenicity Locus of Clostridium Difficile
Hundsberger, T., Braun, V., Weidmann, M., Leukel, P., Sauerborn, M., & Von Eichel‐Streiber, C. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00735.x · Cited by 189
Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile
O'Connor, J. R., Galang, M. A., Sambol, S. P., Hecht, D. W., Vedantam, G., Gerding, D. N., & Johnson, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-08 · Cited by 187
Hospital disinfectants and spore formation by Clostridium difficile
Wilcox, M. H., & Fawley, W. N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02819-1 · Cited by 185
Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function
Jank, T., Giesemann, T., & Aktories, K. (2007) · Glycobiology · doi:10.1093/glycob/cwm004 · Cited by 183
Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?
Rupnik, M. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01687.x · Cited by 181
Carter, G. P., Lyras, D., Allen, D. L., Mackin, K. E., Howarth, P. M., O’Connor, J. R., & Rood, J. I. (2007) · Journal of Bacteriology · doi:10.1128/jb.00731-07 · Cited by 171
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Dial, S., Kezouh, A., Dascal, A., Barkun, A., & Suissa, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071812 · Cited by 166
The Comparative Pathology of Clostridium difficile-associated Disease
Keel, M. K., & Songer, J. G. (2006) · Veterinary Pathology · doi:10.1354/vp.43-3-225 · Cited by 166
Efficacy of Hospital Cleaning Agents and Germicides Against Epidemic Clostridium difficile Strains
Fawley, W. N., Underwood, S., Freeman, J., Baines, S. D., Saxton, K., Stephenson, K., Owens, R. C., & Wilcox, M. H. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/519201 · Cited by 165
(2005) · PubMed · Cited by 164
Recurrences of Clostridium difficile Diarrhea Not Caused by the Original Infecting Organism
Johnson, S., Adelmann, A., Clabots, C. R., Peterson, L. R., & Gerding, D. N. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.340 · Cited by 163
Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes
Rupnik, M. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00110.x · Cited by 159
Metronidazole Resistance in Clostridium difficile Is Heterogeneous
Peláez, T., Cercenado, E., Alcalá, L., Marín, M., Martín-López, A., Martínez-Alarcón, J., Catalán, P., Sánchez-Somolinos, M., & Bouza, E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00524-08 · Cited by 157
Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile
Tan, K. S., Wee, B. Y., & Song, K. P. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-7-613 · Cited by 153
Freeman, J., Baines, S. D., Jabes, D. L., & Wilcox, M. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki321 · Cited by 149
Labbé, A., Poirier, L., MacCannell, D., Louie, T., Savoie, M., Béliveau, C., Laverdière, M., & Pépin, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00146-08 · Cited by 148
The Comprehensive Sourcebook of Bacterial Protein Toxins
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088445-2.x5000-8 · Cited by 148
AMIMOTO, K., Noro, T., Oishi, E., & Shimizu, M. (2007) · Microbiology · doi:10.1099/mic.0.2006/002287-0 · Cited by 147
Clostridium difficile toxin synthesis is negatively regulated by TcdC
Dupuy, B., Govind, R., Antunes, A., & Matamouros, S. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47775-0 · Cited by 143
Systematic Review of Antimicrobial Drug Prescribing in Hospitals
Davey, P., Brown, E., Fenelon, L., Finch, R., Gould, I., Holmes, A., Ramsay, C., Taylor, E., Wiffen, P., & Wilcox, M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1202.050145 · Cited by 137
Surveillance for community-associated clostridium difficile--Connecticut, 2006
(2008) · PsycEXTRA Dataset · doi:10.1037/e458052008-003 · Cited by 120
Clostridium difficile–associated diarrhea: an emerging threat to pregnant women
Rouphael, N., O’Donnell, J. A., Bhatnagar, J., Lewis, F. M. T., Polgreen, P. M., Beekmann, S. E., Guarner, J., Killgore, G., Coffman, B., Campbell, J., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.062 · Cited by 119
Relapse versus reinfection withClostridium difficile
O'Neill, G. L., Beaman, M. H., & Riley, T. V. (1991) · Epidemiology and Infection · doi:10.1017/s0950268800049323 · Cited by 111
Effects of Clostridium difficile Toxins on Epithelial Cell Barrier
Pothoulakis, C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05263.x · Cited by 103
Human antibody response to surface layer proteins in Clostridium difficile infection
Drudy, D., Calabi, E., Kyne, L., Sougioultzis, S., Kelly, E., Fairweather, N., & Kelly, C. P. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.03.007 · Cited by 102
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh285 · Cited by 100
gp96 Is a Human Colonocyte Plasma Membrane Binding Protein for Clostridium difficile Toxin A
Na, X., Kim, H., Moyer, M. P., Pothoulakis, C., & LaMont, J. T. (2008) · Infection and Immunity · doi:10.1128/iai.00326-08 · Cited by 100
Ausiello, C. M., Cerquetti, M., Fedele, G., Spensieri, F., Palazzo, R., Nasso, M., Frezza, S., & Mastrantonio, P. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.07.009 · Cited by 98
Clostridium difficile Toxinotype V, Ribotype 078, in Animals and Humans
Rupnik, M., Widmer, A., Zimmermann, O., Eckert, C., & Barbut, F. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00598-08 · Cited by 97
Revised nomenclature of Clostridium difficile toxins and associated genes
Rupnik, M. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45810-0 · Cited by 96
Proteomic analysis of cell surface proteins from Clostridium difficile
Wright, A., Wait, R., Begum, S., Crossett, B., Nagy, J., Brown, K., & Fairweather, N. (2005) · PROTEOMICS · doi:10.1002/pmic.200401179 · Cited by 91
Brooks, S., Khan, A., Stoica, D., Griffith, J., Friedeman, L., Mukherji, R., Hameed, R., & Schupf, N. (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647824 · Cited by 89
Péchiné, S., Janoir, C., & Collignon, A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5018-5025.2005 · Cited by 85
Jernigan, J. A., Siegman-Igra, Y., Guerrant, R. C., & Farr, B. M. (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647855 · Cited by 81
Hamm, E. E., Voth, D. E., & Ballard, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604725103 · Cited by 80
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model
Baines, S. D., O'Connor, R., Saxton, K., Freeman, J., & Wilcox, M. H. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn502 · Cited by 79
Treatment of Clostridium difficile colitis and diarrhea with vancomycin
Silva, J., Batts, D. H., Fekety, R., Plouffe, J. F., Rifkin, G. D., & Baird, I. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90369-7 · Cited by 78
Clostridium difficileSurveillance Trends, Saxony, Germany
Burckhardt, F., Friedrich, A., Beier, D., & Eckmanns, T. (2008) · Emerging infectious diseases · doi:10.3201/eid1404.071023 · Cited by 75
Calabi, E., & Fairweather, N. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.14.3886-3897.2002 · Cited by 63
Fawley, W. N., Freeman, J., Smith, C., Harmanus, C., van den Berg, R. J., Kuijper, E. J., & Wilcox, M. H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01764-07 · Cited by 60
Cytotoxic Effects of the Clostridium difficile Toxins
Thelestam, M., & Chaves‐Olarte, E. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06272-2_4 · Cited by 57
Merrigan, M. M., Sambol, S. P., Johnson, S., & Gerding, D. N. (2003) · The Journal of Infectious Diseases · doi:10.1086/379836 · Cited by 57
Baines, S. D., O'Connor, R., Saxton, K., Freeman, J., & Wilcox, M. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn358 · Cited by 57
Borgmann, S., Kist, M., Jakobiak, T., Reil, M., Scholz, E., von Eichel-Streiber, C., Gruber, H., Brazier, J. S., & Schulte, B. (2008) · Eurosurveillance · doi:10.2807/ese.13.49.19057-en · Cited by 56
Saxton, K., Baines, S. D., Freeman, J., O'Connor, R., & Wilcox, M. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00306-08 · Cited by 53
Brooks, S., Khan, A. A., Stoica, D., et al. (1998) · Infection Control and Hospital Epidemiology · doi:10.2307/30141374 · Cited by 48
Jernigan, J. A., Siegman‐Igra, Y., Guerrant, R. C., et al. (1998) · Infection Control and Hospital Epidemiology · doi:10.2307/30141397 · Cited by 45
Rates of Clostridium difficile Infection in Patients Discharged From Spanish Hospitals, 1997-2005
Soler, P., Nogareda, F., & Cano, R. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/590392 · Cited by 39
Does the Nose Know? The Odiferous Diagnosis of Clostridium difficile-Associated Diarrhea
Burdette, S. D., & Bernstein, J. M. (2007) · Clinical Infectious Diseases · doi:10.1086/513033 · Cited by 28
Merrigan, M. M. (2003) · Anaerobe · doi:10.1016/s1075-9964(03)00063-5 · Cited by 25
Inappropriate use of meta-analysis to estimate efficacy of probiotics.
Dendukuri, N., & Brophy, J. M. (2007) · PubMed · Cited by 20
Clostridium difficile associated diarrhoea: how good are nurses at identifying the disease?
Johansen, A. (2002) · Age and Ageing · doi:10.1093/ageing/31.6.487-a · Cited by 20
Lewis, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.00916.x · Cited by 18
Cross-Contamination of Clostridium difficile Spores on Bed Linen During Laundering
Hellickson, L., & Owens, K. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.04.025 · Cited by 16
Diagnosis of Clostridium difficile-Associated Diarrhea and Odor
Wilcox, M. H. (2007) · Clinical Infectious Diseases · doi:10.1086/521944 · Cited by 7
Research works printed but not linked: 5
- Summary points on quarterly (October to December. 2008) and financial year (2007/08) acute Trust Clostridium difficile data. Key points: analyses of quarterly mandatory Clostridium difficile surveillance data. Health Protection Agency [online] , (2008).
- Thompson, A. et al. in Ninth Biennial Congress of the Anaerobe Society of Americas. PII-14 (Long Beach, California, 2008).
- Angulo, F. et al. in Second International Clostridium difficile Symposium. P5 (Maribor, Slovenia, 2007).
- Louie, T. et al. in The 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. K-425a (Chicago, Illinois, 2007).
- Merrigan, M. M., Gerding, D. N. & Vedantam, G. in Eighth Biennial Conference of the Anaerobe Society of America. PI-12 (Boise, Idaho, 2006).
Cited by
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371
Host Biology in Light of the Microbiome: Ten Principles of Holobionts and Hologenomes
Bordenstein, S. R., & Theis, K. R. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002226 · Cited by 1,240
Metadata
- Authors
- Rupnik, M., Wilcox, M. H., & Gerding, D. N.
- Affiliations
- University of Maribor (SI)
- Leeds General Infirmary (GB)
- Loyola University Chicago (US)
- Venue
- Nature Reviews Microbiology
- Published
- 2009-07
- Volume
- 7
- Issue
- 7
- Pages
- 526-536
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1968953113
- Cited by
- 1,380
- References
- 124
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 49 · 2023: 59 · 2022: 74 · 2021: 72 · 2020: 88 · 2019: 78 · 2018: 109 · 2017: 104 · 2016: 107 · 2015: 107 · 2014: 133 · 2013: 141 · 2012: 93
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Clostridium difficile infection, nosocomial infections, virulence factors, epidemiology, pathogenesis, community-acquired infections, food-producing animals, antibiotic-associated diarrhea, clinical outcomes, infection prevention and treatment
- MeSH terms
- Animals, Anti-Bacterial Agents, Enterocolitis, Pseudomembranous, Humans, Models, Theoretical, Clostridioides difficile, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.